文献速递重症综合管理与镇静镇痛

重症患者中心静脉导管相关血栓形成危险因素分析及列线图预测模型构建

[Risk factors analysis of central venous catheter-related thrombosis in critically ill patients and development of nomogram prediction model].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论重症患者中心静脉导管相关血栓发生率为16.1%,现有肿瘤、高APACHE II评分、置管后第3天D-二聚体升高及右颈内静脉最大流速降低为独立危险因素,列线图模型AUC 0.820。

该前瞻性调查研究纳入衡水市人民医院2018年5月至2021年3月住院期间接受中心静脉置管的385例重症患者,置管后每日行彩色多普勒超声检查,按是否形成导管相关血栓分为血栓组与非血栓组。结果显示中心静脉导管相关血栓发生率为16.1%(62/385)。多因素Logistic回归显示高APACHE II评分、现有肿瘤、置管后第3天D-二聚体水平高、置管后第3天右颈内静脉最大流速慢为独立危险因素,据此构建列线图预测模型,AUC为0.820(95%CI 0.767-0.872,P<0.001),校准曲线显示预测概率与实际发生概率一致性良好。

要点

  • 385例重症置管患者中中心静脉导管相关血栓发生率为16.1%(62/385),置管后每日彩色多普勒超声筛查。
  • 血栓组APACHE II评分17(15, 19) vs 非血栓组15(12, 18),现有肿瘤比例51.6%(32/62) vs 35.3%(114/323),置管后第3天D-二聚体0.84(0.64, 0.94) mg/L vs 0.57(0.44, 0.76) mg/L,均P<0.05。
  • 血栓组置管后第3天右颈内静脉最大流速14(13, 15) cm/s vs 非血栓组16(14, 18) cm/s,P<0.05。
  • 多因素分析:高APACHE II评分OR 0.876(95%CI 0.801-0.957,P=0.003)、现有肿瘤OR 0.482(95%CI 0.259-0.895,P=0.021)、置管后第3天高D-二聚体OR 0.039(95%CI 0.011-0.139,P<0.001)、置管后第3天右颈内静脉最大流速慢OR 1.401(95%CI 1.218-1.611,P<0.001)为独立危险因素
  • 列线图模型AUC 0.820(95%CI 0.767-0.872,P<0.001),校准曲线显示预测概率与实际发生概率一致性良好。

适用人群与场景

  • 衡水市人民医院2018年5月至2021年3月住院期间接受中心静脉置管的重症患者385例,前瞻性调查。

诊断标准与关键阈值

  • 置管后每日行彩色多普勒超声检查,按是否形成中心静脉导管相关血栓分为血栓组与非血栓组。

研究设计与关键结果

  • 前瞻性调查研究,385例重症置管患者,中心静脉导管相关血栓发生率为16.1%(62/385)。
  • 血栓组 vs 非血栓组:APACHE II评分17(15, 19) vs 15(12, 18),现有肿瘤比例51.6%(32/62) vs 35.3%(114/323),置管后第3天D-二聚体0.84(0.64, 0.94) mg/L vs 0.57(0.44, 0.76) mg/L,均P<0.05;置管后第3天右颈内静脉最大流速14(13, 15) cm/s vs 16(14, 18) cm/s,P<0.05。
  • 多因素Logistic回归:高APACHE II评分OR 0.876(95%CI 0.801-0.957,P=0.003)、现有肿瘤OR 0.482(95%CI 0.259-0.895,P=0.021)、置管后第3天高D-二聚体OR 0.039(95%CI 0.011-0.139,P<0.001)、置管后第3天右颈内静脉最大流速慢OR 1.401(95%CI 1.218-1.611,P<0.001)为独立危险因素。
  • 列线图模型AUC 0.820(95%CI 0.767-0.872,P<0.001),校准曲线显示预测概率与实际发生概率一致性良好。

证据类型、等级与局限

  • 证据类型:前瞻性调查研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对重症置管患者,现有肿瘤、高APACHE II评分、置管后第3天D-二聚体升高及右颈内静脉最大流速降低者发生中心静脉导管相关血栓风险更高,原文据此构建列线图预测模型,AUC 0.820(95%CI 0.767-0.872,P<0.001),校准曲线显示预测概率与实际发生概率一致性良好。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the risk factors of central venous catheter-related thrombosis (CRT) in critically ill patients and develop the model of a nomogram.

METHODS: A prospective investigation study was conducted on 385 critically ill patients who received central venous catheters during hospitalization in Hengshui People's Hospital from May 2018 to March 2021. Color Doppler ultrasonography was performed daily after catheterization. Patients were divided into thrombosis group and non-thrombosis group according to whether CRT was formed. The patient's gender, age, body mass index (BMI), acute physiology and chronic health evaluation II (APACHE II) score, complications, existing tumor, D-dimer level on the 3rd day after catheterization, maximum velocity of right internal jugular vein on the 3rd day after catheterization, mechanical ventilation time, and catheter indwelling time were recorded, and the differences of above indexes between the two groups were compared. Multivariate Logistic regression was performed on the influencing factors with statistical differences between the two groups to establish the nomogram prediction. The receiver operator characteristic curve (ROC curve) and calibration curve were used to evaluate the predictive power of the model.

RESULTS: The incidence of central venous CRT in critically ill patients was 16.1% (62/385). Compared with non-thrombosis patients, the thrombosis group patients had higher APACHE II score, the proportion of existing tumor, and D-dimer level on the 3rd day after catheterization [APACHE II score: 17 (15, 19) vs. 15 (12, 18), the proportion of existing tumor: 51.6% (32/62) vs. 35.3% (114/323), D-dimer (mg/L): 0.84 (0.64, 0.94) vs. 0.57 (0.44, 0.76), all P < 0.05], the maximum flow rate of right internal jugular vein was slower on the 3rd day after catheterization [cm/s: 14 (13, 15) vs. 16 (14, 18), P < 0.05]. Univariate analysis showed that high APACHE II score, critical patients with existing tumor, high D-dimer level on the 3rd day after catheterization, and slow maximum flow rate of right internal jugular vein on the 3rd day after catheterization were more likely to develop central venous CRT. Further multivariate Logistic regression analysis showed that high APACHE II score, existing tumor, high D-dimer level on the 3rd day after catheterization and slow maximum flow rate of right internal jugular vein on the 3rd day after catheterization were independent risk factors for central venous CRT in critical patients [odds ratio (OR) and 95% confidence interval (95%CI) were 0.876 (0.801-0.957), 0.482 (0.259-0.895), 0.039 (0.011-0.139), 1.401 (1.218-1.611), and P values were 0.003, 0.021, < 0.001, < 0.001, respectively]. According to the results of multivariate analysis, the prediction model of the nomogram was constructed. The area under ROC curve (AUC) was 0.820, 95%CI was 0.767-0.872, P < 0.001. The calibration curve showed that the prediction probability of central venous CRT nomogram model in critically ill patients had good consistency with the actual occurrence probability.

CONCLUSIONS: Existing tumor, high APACHE II score, elevated D-dimer on the 3rd day after catheterization, and decreased maximum velocity of right internal jugular vein on the 3rd day after catheterization are independent risk factors for central venous CRT in critical patients. The prediction model based on the proposed model has good clinical efficacy.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang N, Guo Z, Zhang Y, et al. [Risk factors analysis of central venous catheter-related thrombosis in critically ill patients and development of nomogram prediction model]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34839859. doi:10.3760/cma.j.cn121430-20210712-01044

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。